Belgian university hospitals invest €14 million in new cell and gene therapy facility

EURACTIV - Belgian university hospitals UZ Leuven and KU Leuven are investing €14 million in a new facility for the production of Advanced Therapy Medicinal Products (ATMPs). It's expected to be operational by the end of 2025. Read more

The decision to invest in the ATMP facility will enable UZ Leuven to support both investigator-initiated trials and co-development projects with biotech and pharma.